west china medical publishers
Author
  • Title
  • Author
  • Keyword
  • Abstract
Advance search
Advance search

Search

find Author "胡盛寿" 49 results
  • “一站式”复合技术在心血管外科的应用

    “一站式”复合(Hybrid)技术是在同一空间和时间内运用心血管介入与外科手术的复合技术,充分发挥心血管介入治疗和外科手术的优势,治疗复杂的心血管疾病。“一站式”复合技术治疗心血管疾病是当今心脏外科领域中一个全新的治疗理念,其意义在于:以患者为中心,融合多学科的知识和理念,针对患者不同的病理生理状态,设计出最佳的治疗组合方案,从而以最小的代价,获得最佳的疗效。  随着介入治疗技术和外科治疗技术的发展,两种技术的优势和缺陷也逐渐被人们所认识。以先天性心脏病为例,介入治疗尽管得到很大程度的发展,但仍有很大的局限性,如新生儿和小婴儿介入治疗的径路问题。外科治疗仍然是复杂先天性心脏病主要治疗方式,但手术创伤大,并发症多。现代医学的发展要求打破专科的壁垒,真正体现患者至上的原则。因此,联合介入治疗和外科治疗,两种技术的优势互补必将成为未来心血管外科发展的趋势,尤其是“一站式”复合技术手术室硬件条件的具备,使这种技术融合得到更大程度的发挥。 “一站式”复合技术在冠心病、先天性心脏病和大血管疾病方面都得到了很好的应用。冠心病治疗方面,由于乳内动脉旁路移植手术的远期高通畅率得到公认,小切口、胸腔镜辅助或者全内镜下的乳内动脉至左前降支旁路移植手术,经皮冠状动脉内支架植入治疗右冠状动脉和左回旋支动脉,这样的“一站式”复合技术在治疗冠状动脉多支病变取得了很好的疗效,甚至可用于治疗左主干病变。先天性心脏病治疗方面,受血管径路的限制,一些介入治疗在新生儿和小婴儿受到限制,如新生儿和小婴儿室间隔完整的肺动脉闭锁、严重肺动脉狭窄、左心室发育不良综合征等,通过外科手术径路可以安全有效地施行介入治疗。郑哲、李守军等的论文中提及的法洛四联症合并体肺侧支血管形成的治疗也是“一站式”复合技术应用的很好例证。大血管疾病治疗方面,针对A型主动脉夹层的“全主动脉弓置换+支架象鼻技术”和针对B型夹层的全弓置换+远端支架血管植入技术明显提高了手术的安全性和降低术后并发症的发生率。“一站式”复合技术在心血管疾病治疗领域中的应用可降低术后并发症,提高心血管外科手术疗效,节省因并发症导致医疗资源的消耗,而且可使许多高风险患者得到有效的治疗。郑哲、李守军等的“分期和一站式Hybrid手术治疗法洛四联症合并体肺侧支血管形成的疗效比较”一文比较了“一站式”复合技术和传统分期复合技术的疗效。对于合并体肺侧支的紫绀型先天性心脏病,既往的治疗方式包括:术前封堵体肺侧支,封堵后患者快速转送手术室或者等待数天后进行手术治疗;术中尽量寻找并结扎体肺侧支,然后进行手术治疗;手术治疗后,如果出现肺渗出的征象则进行心血管造影和侧支封堵(补救式),如作者所述,这些治疗方式都有一定的缺陷,而“一站式”复合技术则很好地结合介入治疗优势,在外科手术根治的同时处理侧支循环,与传统的方法比较安全有效,更重要的是在医疗资源,如ICU时间、住院时间等方面显示出优势。 “一站式”复合技术的应用真正体现了心血管疾病的整体治疗观念,改变以往心血管外科和心血管介入治疗各行其是的格局,并逐渐呈现具有“杂交”优势的新学科,在心血管疾病的治疗,尤其是对重症、老龄和幼龄患者将发挥巨大的优势。但是,作为一项新的技术或者新的学科,需要更多类似或者前瞻性设计的临床研究验证她的疗效和优势。

    Release date:2016-08-30 06:06 Export PDF Favorites Scan
  • Commentary on series of Chinese expert consensus on surgical treatment of congenital heart diseases

    If one word is used to describe the development of congenital heart disease surgery in China, "hardship" would be the most appropriate. Generations of pioneers have used their ingenuity to overcome obstacles and promoted the development of the discipline. Seventy years of efforts have established the world's largest congenital heart disease treatment system. However, the huge number of potential patients, low early diagnosis rate and over-screening as well as the uneven developed diagnosis and treatment capabilities hinder the future development. The overall improvement of treatment of congenital heart disease in China lies on more efforts from our fellow experts. The publication of the "Chinese expert consensus on surgical treatment of congenital heart diseases" undoubtedly provides theoretical and practical guidance for the improvement of treatment.

    Release date:2021-02-22 05:33 Export PDF Favorites Scan
  • Progress in Surgical Treatment of Secondary Tricuspid Insufficiency

    Abstract: Tricuspid insufficiency founded in the setting of left-sided heart disease is usually secondary tricuspid insufficiency caused by tricuspid valve annular dilation. Some patients had rheumatic tricuspid valve diseases. Tricuspid valve repair rather than valve replacement is recommend for functional tricuspid regurgitation. Linear annuloplasty and ring annuloplasty are two main tricuspid valve repair methods. However, the indications for treatment of secondary tricuspid regurgitation remain controversial. The optimal surgical repair technique to eliminate secondary tricuspid regurgitation remains challenging. In this article, we review the assessment of tricuspid valve lesions, criteria for correction, and surgical management of secondary tricuspid insufficiency.methods. However, the indications for treatment of secondary tricus

    Release date:2016-08-30 05:49 Export PDF Favorites Scan
  • 冠状动脉瘤的诊断与治疗

    冠状动脉瘤是一种少见的心脏病,凡能导致冠状动脉中层结构和功能削弱的因素,均可导致冠状动脉瘤的形成.因此,其临床表现不具有特异性,与单纯冠状动脉狭窄患者的临床表现相似.目前虽然有多种方法可明确诊断,但冠状动脉造影仍为诊断该病的主要方法,其作用不可替代.冠状动脉瘤易发生血栓、栓塞、瘤体破裂和血管痉挛等并发症,预后差,应尽早治疗.手术治疗较药物治疗、介入治疗疗效明确,手术原则是切除冠状动脉瘤,行冠状动脉旁路移植术,并同时处理合并的病变.

    Release date:2016-08-30 06:32 Export PDF Favorites Scan
  • Early and Mid-term Follow-up Outcomes of“One-stop” Hybrid Coronary Revascularization for Patients with Multivessel Coronary Artery Disease

    Abstract: Objectives To evaluate the early and mid-term follow-up outcomes of “one-stop” hybrid coronary revascularization strategy for patients with multivessel coronary artery disease. Methods From June 2007 to December 2009, 104 consecutive patients underwent “one-stop”hybrid coronary revascularization in Fu Wai Hospital. There were 93 male patients and 11 female patients with mean age of (61.8±10.2)years(ranging from 35 to 81 years). All the patients had multivessel coronary artery disease including left anterior descending (LAD)coronary artery stenosis, and underwent “one-stop”hybrid coronary revascularization. “One-stop”hybrid procedure was first performed through a lower partial sternotomy at the second left intercostal space. The distal anastomosis of in situ left internal mammary artery (LIMA)to LAD graft was completed. Angiography was performed immediately to confirm patency of the LIMA graft after closure of the thorax. A 300 mg loading dose of clopidogrel was administered through a nasogastric tube after confirmation of LIMA graft patency. Intravenous unfractionated heparin was administered to obtain an activated clotting time of greater than 250 s. Then percutaneous coronary intervention(PCI)was performed on the non-LAD lesions. Results All the patients underwent“one-stop”hybrid coronary revascularization including grafted LIMA to LAD,and one hundred and ninety one drug eluting stents and three bare metal stents were used for other non-LAD lesions. No death event occurred during surgery and in hospital. All the patients were followed up for a mean duration of 1.5 years. There was no myocardial infarction, neurologic event or death occurred during follow-up except one patient with stent stenosis who was treated by PCI. Conclusion “One-stop” hybrid coronary revascularization is a feasible and safe alternative for patients with multivessel coronary artery disease.

    Release date:2016-08-30 05:50 Export PDF Favorites Scan
  • Realtime Threedimensional Echocardiography Evaluation in Changes of Left Ventricular Regional Systolic Function after Surgical Treatment of Left Ventricular Aneurysm

    Abstract: Objective To investigate changes of left ventricularregional systolic function after surgical treatment of left ventricular aneurysm (LVA) by realtime threedimensional echocardiography (RT-3DE). Methods From February 2009 to February 2010, 14 consecutive patients who were diagnosed to have coronary artery diseases with LVA underwent surgical repair and coronary artery bypass grafting (LVA group) in our hospital. All patients of the LVA group were followed up for a mean period of 4 months. Twodimensional echocardiography (2DE) and RT-3DE were performed before operation and during the follow-up. Left ventricular regional ejection fraction (EF) was acquired by Qlab software analysis. At the same time, 12 healthy persons were included as controls (control group). Statistical analyses were carried out to compare left ventricular regional EF between the LVA group (before operation and 4 months after operation) and the control group. Results Contrary to the control group, preoperative regional EF of the LVA group increased from apex to base. In addition to the inferior basal segment, lateralinferior basal segment and anteriorinferior basal segment, regional EF in the remaining 14 segments were significantly lower than that of the control group (P<0.05). At postoperative followup, regional EF recovered the increase from base to apex, and there was no significant difference between anteriorinferior segment and lateral segment regional EF of the LVA group and those of the control group (P>0.05), while regional EF of other segments in the LVA group was lower than that in the control group (P<0.05). Conclusion RT-3DE is an effective method to assess left ventricular regional systolic function in patients with LVA. After LVA repair and coronary artery bypass grafting, regional systolic function will restore to the normal direction of progressive increase, and some nonaneurysm segments systolic function will go back to normal.

    Release date:2016-08-30 05:57 Export PDF Favorites Scan
  • Clinical Application of Homemade Flexible Annuloplasty Ring in Mitral Valve Repair

    Abstract: Objective To summarize the clinical results of homemade flexible annuloplasty ring in mitral valve repair, in order to discuss the appropriate ring size. Methods Sixtysix patients (55 males,and 11 females with a mean age of 44.62±15.94 years) with mitral insufficiency underwent mitral valve repair with homemade flexible annuloplasty ring from April 2002 to November 2009 in Fu Wai Hospital. In order to choose the ring with an appropriate size, we made and kept to the following principles: if the intercommissural distance was bigger than size 30, we chose a ring 2size smaller; if the measured distance was smaller than size 30, 1size smaller ring would be chosen. Patients were followed by echocardiography to observe the mitral valve function. Results All patients were cured and discharged from the hospital. The results of echocardiography showed mild to moderate regurgitation in 1 patient, mild regurgitation in 11 patients, and normal mitral function or trace regurgitation in the rest 54 patients. Mitral valve forward velocity was 1.40±0.30 m/s with no mitral stenosis or systolic anterior motion (SAM) of the anterior mitral leaflet. Fiftyone patients were followed up from 2 months to 7 years(24.60±25.90 months). The results of echocardiography on 38 patients showed that 1 patient had moderate regurgitation, 5 patients had mild to moderate regurgitation, 9 patients had mild regurgitation and others had normal mitral function or trace regurgitation. For these 38 patients included in the followup study, mitral valve forward velocity was 1.50±0.40 m/s with no mitral stenosis, SAM or left ventricular outlet tract obstruction. During the followup, the left atrium size (43.19±10.48 mm vs. 48.59±9.40 mm, t=4.524, P=0.000) and left ventricular end diastolic diameter (52.64±7.35 mm vs. 6269±8.77 mm, t=7.607, P=0.000) decreased significantly than the preoperative size and diameter respectively.  The application of restrictive homemade flexible annuloplasty ring in mitral valve annuloplasty had satisfactory, durable and stable clinical results.

    Release date: Export PDF Favorites Scan
  • Impact of Dual Antiplatelet Therapy on Postoperative Bleeding and Blood Transfusion in Coronary Artery Bypass Grafting

    Objective [WTBZ]To assess the impact of dual antiplatelet therapy using aspirin and clopidogrel on postoperative bleeding and blood transfusion early after coronary artery bypass grafting (CABG). Methods [WTBZ]In this randomized controlled trial, 249 patients were randomly assigned to 2 groups after coronary artery bypass grafting from December 2007 to December 2008. Daily clopidogrel (75 mg) and aspirin (100 mg) were initiated in 124 patients (group AC) while aspirin (100 mg) alone was administered to 125 patients (group A). Antiplatelet therapy was initiated within 48h postoperatively. Demographic, operative, and postoperative data were compared between the two groups. Chest tube drainage and quantity of blood products used in both groups were recorded. The effects of the antiplatelet regimen on chest tube drainage were compared using a linear regression model. Results [WTBZ]No statistical difference of demographic, operative, and preoperative data was observed between the two groups (Pgt;0.05). Chest tube drainage after patients received ntiplatelet agents was not significantly different between group A and group AC(495.00±270.89 ml vs. 489.25±316.68ml,t=0.146, P=0.884). No statistical difference of cases of transfusion(81 cases vs. 91 cases,χ2=1.937, P=0.164) or quantity of red cells (2.51±2.88 U vs. 2.25±2.87 U, t=0.690, P=0.491) and plasma (195.45±300.88 ml vs. 223.01±238.68 ml,t=0.759, P=0.449) transfused was found between group A and group AC. No perioperative mortality, reexploration or extrathoracic bleeding occurred in either group. Early postoperative use of dual antiplatelet therapy was not associated with increased bleeding after coronary artery bypass grafting on multivariable analysis(r=2.297,95%CI:-64.526,69.121,P=0.946). Conclusionpresent study suggests that according to a predefined administration protocol, dual antiplatelet therapy of aspirin and clopidogrel can safely be administered in the early postoperative period in CABG patients, without increasing the risk of bleeding complications.

    Release date:2016-08-30 05:59 Export PDF Favorites Scan
  • Longterm Results of Coronary Artery Bypass Grafting in the Treatment of Ischemic Cardiac Diseases with Heart Insufficiency

    Objective To evaluate the longterm results of coronary artery bypass grafting (CABG) in treating cardiac diseases with heart insufficiency by analyzing the longterm survival rate and heart failure exemption rate of the patients. Methods A total of 239 patients who had coronary heart disease with left heart dysfunction (LVEFlt;40%) were enrolled in our study. Among the patients, there were 215 males and 24 females aged from 32 to 78 years old with an average age of 59.1. Before operation, 193 patients had a past history of myocardial infarction and 31 had angina. According to the New York heart function assessment (NYHA), 26 patients were categorized as class Ⅰ, 106 as class Ⅱ, 73 as class Ⅲ and 34 as class Ⅳ. Coronary angiography showed 10 cases (4.2%) of single vessel disease, 35 cases (14.6%) of double vessel disease and 194 cases (81.2%) of triple vessel disease. The result of preoperative ultrasound cardiogram showed that LVEF was 35.7%±4.6%. All patients received CABG, including 153 (64.0%) onpump surgeries and 86 (35.9%) offpump surgeries. Selective operation was done on 237 patients and there were 2 emergency cases. Valve repair or replacement, ventricular aneurysmectomy or aneurysm plication were not carried out during the operation. Results There were 1 to 6 (3.4±1.1) bypass grafting vessels in each case. Five (2.09%) patients died during the hospital stay, among which 2 died of low cardiac output and circulation failure, 1 died of malignant arrhythmia, 1 died of renal failure, and 1 died of coma with multiorgan failure. The followup period was 512±1.79 years. During the followup, 18 patients (7.7%) were lost and 29 patients died. Among them, there were 24 cardiac deaths and the cardiac death rate at the first year and the fifth year was 2.8% and 9.4% respectively. There were 40 cases of heart failure during the followup period. The exemption rate of heart failure was 93.7% and 81.8% at the first year and the fifth year respectively. The survival rate was 97.2% at the first year and 89.3% at the fifth year. Conclusion The longterm result of CABG in treating patients with ischemic heart insufficiency is satisfying.

    Release date:2016-08-30 06:02 Export PDF Favorites Scan
  • Risk Factors for Mortality in the Arterial Switch Operation

    Abstract: Objective To analyze risk factors for perioperative mortality in the arterial switch operation (ASO), in order to provide better operation and decrease the mortality rate. Methods We enrolled 208 ASO patients including 157 males and 51 females at Fu Wai Hospital between January 1, 2001 and December 31, 2007. The age ranged from 6 h to 17 years with the median age of 90 d and the weight ranged from 3 kg to 43 kg with the median weight of 5 kg. Among the patients, 127 had transposition of great artery (TGA) with ventricular septal defect (VSD), and 81 patients had TGA with intact ventricular septum (IVS) or with the diameter of VSD smaller than 5 mm. Coronary anatomy was normal (1LCX2R) in 151 patients and abnormal in the rest including 15 patients with single coronary artery, 6 with intramural and 36 with inverse coronary artery. Preoperative, perioperative and postoperative clinical data of all patients were collected to establish a database which was then analyzed by univariate analysis and multivariate logistic regression analysis to find out the risk factors formortality in ASO. Results There were 24 perioperative deaths (11.54%) in which 12 died of postoperative infection with multiple organ failure (MOF), 10 died of low cardiac output syndrome, 1 died of pulmonary hypertension, and 1 died of cerebral complications. Among them, 20 patients (18.30%) died in early years from 2001 to 2005, while only 4 (4.00%) died in the time period from 2006 to 2007, which was a significant decrease compared with the former period (Plt;0.05). The univariate analysis revealed that cardiopulmonary bypass (CPB) time was significantly longer in the death group than in the survival group(236±93 min vs. 198±50 min, P=0.002), and occurrence of major coronary events (33.3% vs. 2.2%, P=0.000) and unusual coronary artery patterns(33.3% vs. 6.5%,P=0.000) were much more in the death group than in the survival group. Multivariate logistic regression analysis showed that early year of [CM(159mm]operation (OR=7.463, P=0.003), unusual coronary artery patterns (OR=6.303,P=0.005) and occurrence of majorcoronary events (OR=17.312, P=0.000) were independent predictors for perioperative mortality. Conclusion The ASO can be performed with low perioperative mortality in our hospital currently. Occurrence of major coronary events, unusual coronary artery patterns and year of surgery before 2006 are independent predictors for perioperative mortality.

    Release date:2016-08-30 06:01 Export PDF Favorites Scan
5 pages Previous 1 2 3 4 5 Next

Format

Content